New Analysis Reveals Icosapent Ethyl Significantly Reduces Risk of Major Cardiovascular Events in Patients with Prior Myocardial Infarction (Heart Attack)

Go back to New Analysis Reveals Icosapent Ethyl Significantly Reduces Risk of Major Cardiovascular Events in Patients with Prior Myocardial Infarction (Heart Attack)

Northland Capital Markets Downgrades Amarin Corporation (AMRN) to Market Perform

May 4, 2022 3:27 PM EDT

Northland Capital Markets analyst Carl Byrnes downgraded Amarin Corporation (NASDAQ: AMRN) from Outperform to Market Perform with a price target of $2.00 (from $9.00).

The analyst comments "We are lowering our rating to MP from OP with a price target of $2/share. US VASCEPA... More